Packages (Simulation)
Reagent Preparation
Image (I)
-
Results demonstration
Quality Guarantee
Certificate
Maybe you can also pay attention to our smart microplate reader
Mini Samples ELISA Kit for Endocrine Gland Derived Vascular Endothelial Growth Factor (EG-VEGF)
PK1; EGVEGF; PRK1, PROK1; Prokineticin 1; Black Mamba Toxin-Related Protein; Mambakine
- Product No.MEA024Mu
- Organism SpeciesMus musculus (Mouse) Same name, Different species.
- Sample Typen/a
- Test MethodDouble-antibody Sandwich
- Assay Length3h
- Detection Rangen/a
- Sensitivityn/a
- Downloadn/a
- UOM 48T96T 96T*5 96T*10 96T*100
- FOB
US$ 545
US$ 778
US$ 3501
US$ 6613
US$ 54460
For more details, please contact local distributors!
Specificity
This assay has high sensitivity and excellent specificity for detection of Mini Samples Endocrine Gland Derived Vascular Endothelial Growth Factor (EG-VEGF).
No significant cross-reactivity or interference between Mini Samples Endocrine Gland Derived Vascular Endothelial Growth Factor (EG-VEGF) and analogues was observed.
Recovery
Matrices listed below were spiked with certain level of recombinant Mini Samples Endocrine Gland Derived Vascular Endothelial Growth Factor (EG-VEGF) and the recovery rates were calculated by comparing the measured value to the expected amount of Mini Samples Endocrine Gland Derived Vascular Endothelial Growth Factor (EG-VEGF) in samples.
| Matrix | Recovery range (%) | Average(%) |
| serum(n=5) | 80-96 | 88 |
| EDTA plasma(n=5) | 91-99 | 95 |
| heparin plasma(n=5) | 91-101 | 94 |
Precision
Intra-assay Precision (Precision within an assay): 3 samples with low, middle and high level Mini Samples Endocrine Gland Derived Vascular Endothelial Growth Factor (EG-VEGF) were tested 20 times on one plate, respectively.
Inter-assay Precision (Precision between assays): 3 samples with low, middle and high level Mini Samples Endocrine Gland Derived Vascular Endothelial Growth Factor (EG-VEGF) were tested on 3 different plates, 8 replicates in each plate.
CV(%) = SD/meanX100
Intra-Assay: CV<10%
Inter-Assay: CV<12%
Linearity
The linearity of the kit was assayed by testing samples spiked with appropriate concentration of Mini Samples Endocrine Gland Derived Vascular Endothelial Growth Factor (EG-VEGF) and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.
| Sample | 1:2 | 1:4 | 1:8 | 1:16 |
| serum(n=5) | 94-102% | 92-101% | 84-98% | 93-102% |
| EDTA plasma(n=5) | 94-101% | 97-104% | 80-104% | 79-94% |
| heparin plasma(n=5) | 92-99% | 96-103% | 91-101% | 84-94% |
Stability
The stability of kit is determined by the loss rate of activity. The loss rate of this kit is less than 5% within the expiration date under appropriate storage condition.
To minimize extra influence on the performance, operation procedures and lab conditions, especially room temperature, air humidity, incubator temperature should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same operator from the beginning to the end.
Reagents and materials provided
| Reagents | Quantity | Reagents | Quantity |
| Pre-coated, ready to use 96-well strip plate | 1 | Plate sealer for 96 wells | 4 |
| Standard | 2 | Standard Diluent | 1×20mL |
| Detection Reagent A | 1×120µL | Assay Diluent A | 1×12mL |
| Detection Reagent B | 1×120µL | Assay Diluent B | 1×12mL |
| TMB Substrate | 1×9mL | Stop Solution | 1×6mL |
| Wash Buffer (30 × concentrate) | 1×20mL | Instruction manual | 1 |
Assay procedure summary
1. Prepare all reagents, samples and standards;
2. Add 100µL standard or sample to each well. Incubate 1 hours at 37°C;
3. Aspirate and add 100µL prepared Detection Reagent A. Incubate 1 hour at 37°C;
4. Aspirate and wash 3 times;
5. Add 100µL prepared Detection Reagent B. Incubate 30 minutes at 37°C;
6. Aspirate and wash 5 times;
7. Add 90µL Substrate Solution. Incubate 10-20 minutes at 37°C;
8. Add 50µL Stop Solution. Read at 450nm immediately.
GIVEAWAYS
INCREMENT SERVICES
| Magazine | Citations |
| Tumor Biology | Hypoxia-induced secretion of IL-14 from adipose-derived mesenchymal stem cell promotes growth and cancer stem cell properties of Burkitt lymphoma PubMed: 26695151 |
| Stem Cells and Development | Lower Senescence of Adipose-Derived Stem Cells than Donor-Matched Bone Marrow Stem Cells for Surgical Ventricular Restoration Pubmed:29630447 |